Evotec leads the way in in vivo pharmacology, boasting unparalleled expertise across key therapeutic areas such as neurosciences, metabolic diseases, oncology, immuno-oncology, infectious disease, inflammation, and immunology. Our dedicated team of over 80 highly experienced scientists brings extensive biopharmaceutical and drug hunting knowledge to the table. From early target validation to candidate selection, we provide comprehensive support for in vivo studies. Whether as stand-alone investigations or as part of integrated drug discovery programs, our flexibility ensures tailored solutions to meet your specific needs. Rest assured - all our animal research adheres to the highest standards of animal welfare. Conducted in state-of-the-art facilities, our experimental procedures are approved in accordance with stringent European Union and national regulations.
Trust Evotec to drive your breakthrough therapies forward with our unrivaled in vivo pharmacology expertise.
